Model-informed precision dosing of beta-lactam antibiotics and ciprofloxacin in critically ill patients: a multicentre randomised clinical trialTim M. J. Ewoldt, Birgit C. P. Koch, Ilse M. Purmer et al.|Intensive Care Medicine|2022Cited by 111
Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning) ModelsAndré Wieringa, Alan Abdulla, Tim M. J. Ewoldt et al.|Antibiotics|2023Cited by 7
Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding StudySammy Huygens, Bart Rijnders, Tim Preijers et al.|Clinical Pharmacokinetics|2024Cited by 5
Target attainment and pharmacokinetics of cefotaxime in critically ill patients undergoing continuous kidney replacement therapyAndré Wieringa, Birgit C. P. Koch, Peter G. J. ter Horst et al.|Journal of Antimicrobial Chemotherapy|2022Cited by 3
Pharmacokinetics of zanamivir in critically ill patients undergoing continuous venovenous hemofiltrationAndré Wieringa, Jasper J. Haringman, Peter GJ ter Horst et al.|Antiviral Therapy|2023Cited by 3